CEL SCI Corp Stock Pattern Recognition Inverted Hammer
| CVM Stock | USD 3.57 0.05 1.42% |
| Symbol |
Recognition |
The output start index for this execution was eleven with a total number of output elements of fifty. The function generated a total of two valid pattern recognition events for the selected time horizon. The Inverted Hammer pattern indicates that the buyers drove prices of CEL SCI Corp up, at some point during the period, but encountered selling pressure which drove prices back down to close near to where they opened.
CEL SCI Technical Analysis Modules
Most technical analysis of CEL SCI help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for CEL from various momentum indicators to cycle indicators. When you analyze CEL charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Stock Overview, Methodology & Data Sources
CEL-SCI Corporation engages in the research and development of immunotherapy for the treatment of cancer and infectious diseases. The company was incorporated in 1983 and is headquartered in Vienna, Virginia. Cel-Sci Corp operates under Biotechnology classification in the United States and is traded on AMEX Exchange. This overview emphasizes how CEL SCI compares to peers on valuation quality and operating consistency. Current metrics include P/B of 2.71. CEL SCI has a market cap of 30.19 M, ROE of -2.12%.
Methodology
Unless otherwise specified, financial data for CEL SCI Corp is derived from periodic company reporting (annual and quarterly where available). Asset-level metrics are computed daily by Macroaxis LLC and refreshed regularly based on asset type. CEL (USA Stocks:CVM) prices are typically delayed by approximately 20 minutes from primary exchanges for listed equities. Data may be delayed depending on reporting sources and market conventions. Assumptions: Inputs are aggregated from public filings and market reference sources and public institutions such as U.S. Securities and Exchange Commission (SEC) via EDGAR and the U.S. Patent & Trademark Office (USPTO). Certain values may not reflect real-time changes. All analytics are generated using standardized, rules-based models designed to promote consistency and comparability across instruments. Model assumptions, reference parameters, and selected computational inputs are available in the Model Inputs section. If you have questions about our data sources or methodology, please contact Macroaxis Support.
Analyst Sources
CEL SCI Corp is covered by 1 analyst. Representative analyst firms may include Stifel, Barclays, Morgan Stanley, Wells Fargo Securities, Evercore ISI, among others. Updates may occur throughout the day.
This content is curated and reviewed by:
Gabriel Shpitalnik - Member of Macroaxis Editorial BoardLearn to be your own money manager
Tracking CEL SCI inside a portfolio is useful because individual winners can still weaken diversification or distort overall risk targets. A disciplined tracking process turns performance data into better decisions instead of more noise.
Did you try this?
Run Portfolio Center Now
Portfolio CenterAll portfolio management and optimization tools to improve performance of your portfolios |
| All Next | Launch Module |
CEL SCI Corp pair trading
Pair trading with CEL SCI can help investors hedge some company-specific exposure by balancing a long view with an offsetting position. The key question is whether the second leg adds real hedge value instead of just creating a more complex version of the same risk.
CEL SCI Pair Trading
CEL SCI Corp Pair Trading Analysis
Replacing CEL SCI with a highly correlated asset during tax-loss harvesting reduces the probability that the portfolio will miss a sudden rally in CEL SCI Corp during the required 30-day waiting period.
For long-term investors in CEL SCI, the relevant correlation horizon is typically monthly or quarterly. Short-term noise in daily CEL SCI Corp correlation estimates can be misleading when constructing buy-and-hold diversified portfolios.
Pair evaluation and Correlation analysis for CEL SCI provide hedging context. The view can be extended across sectors or other related groups.More Resources for CEL Stock Analysis
A structured review of CEL SCI Corp often starts with core financial statements and trend context. Financial ratios provide context for profitability, efficiency, and growth trends. Key reports that frame CEL SCI Corp Stock are listed below:CEL SCI has a market cap of 30.19 M, ROE of -2.12%. Trending Equities can help frame allocation decisions. The allocation includes a position in CEL SCI Corp in the portfolio view. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in private. Analysis related to CEL SCI should be read together with other portfolio and risk tools before capital is reallocated. That is especially important when the goal is to improve the overall mix of instruments already held. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Earnings Share -3.70 | Revenue Per Share | Quarterly Revenue Growth -0.63 | Return On Assets | Return On Equity |
Market capitalization and book value offer complementary views of CEL SCI Corp — the first driven by investor sentiment, the second by accounting standards. CEL SCI's market capitalization is 30.19 M. A P/B ratio of 2.71 indicates the market values CEL SCI above its accounting book value. Enterprise value stands at 33.02 M. The intrinsic value concept focuses on underlying worth, which can diverge from market price and book value. Valuation work aligns these measures into a single context.
Value and price for CEL SCI are related but not identical, and they can diverge across cycles. For CEL SCI, key inputs include a P/B ratio of 2.71, and ROE of -2.12%. Trading price represents the transaction level agreed by market participants.